{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:04:40Z","timestamp":1792184680976,"version":"4.4.0"},"reference-count":325,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["2019-000021-01EXTF-00293"],"award-info":[{"award-number":["2019-000021-01EXTF-00293"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["277722"],"award-info":[{"award-number":["277722"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010622","name":"Fondation des Maladies de l&apos;Oeil","doi-asserted-by":"publisher","award":["115923"],"award-info":[{"award-number":["115923"]}],"id":[{"id":"10.13039\/100010622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["30903"],"award-info":[{"award-number":["30903"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["32608"],"award-info":[{"award-number":["32608"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.semcancer.2020.05.003","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T11:44:28Z","timestamp":1590147868000},"page":"65-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"special_numbering":"C","title":["Uveal melanoma pathobiology: Metastasis to the liver"],"prefix":"10.1016","volume":"71","author":[{"given":"Prisca","family":"Bustamante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9o","family":"Piquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange","family":"Landreville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia V.","family":"Burnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10555-017-9663-3","article-title":"The biology of uveal melanoma","volume":"36","author":"Amaro","year":"2017","journal-title":"Cancer Metastasis Rev."},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0010","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The national cancer data base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer society","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0015","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes","volume":"127","author":"Shields","year":"2009","journal-title":"Arch. Ophthalmol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/eye.2016.275","article-title":"Uveal melanoma: relatively rare but deadly cancer","volume":"31","author":"Kaliki","year":"2017","journal-title":"Eye (Lond.)"},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib0025","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ophtha.2003.07.002","article-title":"Nondiagnosed uveal melanomas","volume":"111","author":"Bove","year":"2004","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0030","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.ophtha.2012.01.048","article-title":"Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients","volume":"119","author":"Damato","year":"2012","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.semcancer.2020.05.003_bib0035","first-page":"1872","article-title":"Uveal melanoma incidence trends in Canada: a national comprehensive population-based study","volume":"103","author":"Ghazawi","year":"2019","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000480640","article-title":"Uveal melanoma: 5-year Update on incidence, treatment, and survival (SEER 1973-2013)","volume":"4","author":"Aronow","year":"2018","journal-title":"Ocul. Oncol. Pathol."},{"issue":"12","key":"10.1016\/j.semcancer.2020.05.003_bib0045","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","article-title":"Incidence of uveal melanoma in Europe","volume":"114","author":"Virgili","year":"2007","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0050","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0161-6420(03)00078-2","article-title":"Incidence of uveal melanoma in the United States: 1973\u20131997","volume":"110","author":"Singh","year":"2003","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0055","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/02713683.2017.1297997","article-title":"Uveal melanoma risk factors: a systematic review of meta-analyses","volume":"42","author":"Nayman","year":"2017","journal-title":"Curr. Eye Res."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archopht.124.1.54","article-title":"The association between host susceptibility factors and uveal melanoma: a meta-analysis","volume":"124","author":"Weis","year":"2006","journal-title":"Arch. Ophthalmol."},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.003_bib0065","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1097\/IAE.0000000000002508","article-title":"Choroidal nevus transformation into melanoma per millimeter increment in thickness using multimodal imaging in 2355 cases: the 2019 Wendell L. Hughes lecture","volume":"39","author":"Shields","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.semcancer.2020.05.003_bib0070","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/386986","article-title":"Evidence for the role of blue light in the development of Uveal Melanoma","volume":"2015","author":"Logan","year":"2015","journal-title":"J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.003_bib0075","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ophtha.2005.04.020","article-title":"Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis","volume":"112","author":"Shah","year":"2005","journal-title":"Ophthalmology"},{"issue":"23","key":"10.1016\/j.semcancer.2020.05.003_bib0080","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"7229","key":"10.1016\/j.semcancer.2020.05.003_bib0085","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"Van Raamsdonk","year":"2009","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0090","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ng.2674","article-title":"Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3","volume":"45","author":"Martin","year":"2013","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/php.12161","article-title":"Implication of ultraviolet light in the etiology of uveal melanoma: a review","volume":"90","author":"Mallet","year":"2014","journal-title":"Photochem. Photobiol."},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.003_bib0100","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.2359","article-title":"Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma","volume":"44","author":"Krauthammer","year":"2012","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2020.05.003_bib0110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.preteyeres.2018.03.004","article-title":"Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death - A personal view","volume":"66","author":"Damato","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.semcancer.2020.05.003_bib0115","series-title":"Clinical Ophthalmic Oncology","article-title":"Uveal melanoma: metastases","author":"Xu","year":"2019"},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0301-4738.154367","article-title":"Uveal melanoma: estimating prognosis","volume":"63","author":"Kaliki","year":"2015","journal-title":"Indian J. Ophthalmol."},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.003_bib0125","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1136\/bjo.2005.069823","article-title":"Whole body PET\/CT for initial staging of choroidal melanoma","volume":"89","author":"Finger","year":"2005","journal-title":"Br. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0130","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archopht.119.5.670","article-title":"Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15","volume":"119","year":"2001","journal-title":"Arch. Ophthalmol."},{"issue":"12","key":"10.1016\/j.semcancer.2020.05.003_bib0135","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","article-title":"Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: collaborative Ocular Melanoma Study Group Report No. 26","volume":"123","author":"Diener-West","year":"2005","journal-title":"Arch. Ophthalmol."},{"issue":"16","key":"10.1016\/j.semcancer.2020.05.003_bib0140","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.ejca.2015.07.013","article-title":"Uveal melanoma UK national guidelines","volume":"51","author":"Nathan","year":"2015","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib0145","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008390-200106000-00007","article-title":"Prognostic factors in uveal melanoma","volume":"11","author":"Singh","year":"2001","journal-title":"Melanoma Res."},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0150","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/jcp.2010.087999","article-title":"The biology of micrometastases from uveal melanoma","volume":"64","author":"Borthwick","year":"2011","journal-title":"J. Clin. Pathol."},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0155","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0161-6420(00)00182-2","article-title":"Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment","volume":"107","author":"Eskelin","year":"2000","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0160","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0161-6420(00)00607-2","article-title":"Uveal melanoma: implications of tumor doubling time","volume":"108","author":"Singh","year":"2001","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00918938","article-title":"Uveal melanoma: therapeutic consequences of doubling times and irradiation results; a review","volume":"16","author":"Manschot","year":"1992","journal-title":"Int. Ophthalmol."},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.003_bib0170","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/bjo.2003.029058","article-title":"The Zimmerman-McLean-Foster hypothesis: 25 years later","volume":"88","author":"Singh","year":"2004","journal-title":"Br. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib0175","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.eye.6702322","article-title":"Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study","volume":"21","author":"Callejo","year":"2007","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.semcancer.2020.05.003_bib0180","article-title":"Detection of circulating malignant cells in a uveal melanoma animal model","volume":"5110","author":"Paula","year":"2004","journal-title":"ARVO Preceedings"},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0185","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10585-008-9158-2","article-title":"Single-cell tumor dormancy model of uveal melanoma","volume":"25","author":"Logan","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/bjophthalmol-2016-309034","article-title":"Metastatic disease from uveal melanoma: treatment options and future prospects","volume":"101","author":"Carvajal","year":"2017","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/archopht.1992.01080140101036","article-title":"A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988","volume":"110","author":"Diener-West","year":"1992","journal-title":"Arch. Ophthalmol."},{"issue":"12","key":"10.1016\/j.semcancer.2020.05.003_bib0200","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1001\/archopht.1983.01040020896012","article-title":"A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma","volume":"101","author":"Seddon","year":"1983","journal-title":"Arch. Ophthalmol."},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.003_bib0205","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.ophtha.2008.04.025","article-title":"Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability","volume":"115","author":"Coupland","year":"2008","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0210","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/cjp2.86","article-title":"Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma","volume":"4","author":"Farquhar","year":"2018","journal-title":"J. Pathol. Clin. Res."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib0215","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0002-9394(98)00040-3","article-title":"Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study. COMS report no. 6","volume":"125","year":"1998","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0220","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/1097-0142(197805)41:5<1897::AID-CNCR2820410534>3.0.CO;2-2","article-title":"Uveal melanomas: correlation of cytologic features with prognosis","volume":"41","author":"Gamel","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2020.05.003_bib0225","doi-asserted-by":"crossref","first-page":"lvi","DOI":"10.1016\/j.ajo.2018.08.025","article-title":"Modifications of Callender\u2019s classification of uveal melanoma at the armed forces institute of pathology","volume":"195","author":"McLean","year":"2018","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0230","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/modpathol.2013.138","article-title":"Genetic and clinico-pathologic analysis of metastatic uveal melanoma","volume":"27","author":"Griewank","year":"2014","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0235","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.1977.04450010050004","article-title":"Prognostic factors in small malignant melanomas of choroid and ciliary body","volume":"95","author":"McLean","year":"1977","journal-title":"Arch. Ophthalmol."},{"issue":"11","key":"10.1016\/j.semcancer.2020.05.003_bib0240","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/0046-8177(92)90299-I","article-title":"The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study","volume":"23","author":"Folberg","year":"1992","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.semcancer.2020.05.003_bib0245","first-page":"502","article-title":"Density of PAS positive patterns in uveal melanoma: correlation with vasculogenic mimicry, gene expression class, BAP-1 expression, macrophage infiltration, and risk for metastasis","volume":"25","author":"Stalhammar","year":"2019","journal-title":"Mol. Vis."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib0250","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","article-title":"Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry","volume":"155","author":"Maniotis","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib0255","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/jnci\/91.4.359","article-title":"Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas","volume":"91","author":"Makitie","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0260","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/1097-0142(19900101)65:1<112::AID-CNCR2820650123>3.0.CO;2-X","article-title":"Lymphocytic infiltration in uveal malignant melanoma","volume":"65","author":"de la Cruz","year":"1990","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0265","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1167\/iovs.10-5979","article-title":"Detection of M2-macrophages in uveal melanoma and relation with survival","volume":"52","author":"Bronkhorst","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0270","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/aos.13645","article-title":"Nestin expression in primary and metastatic uveal melanoma - possible biomarker for high-risk uveal melanoma","volume":"96","author":"Djirackor","year":"2018","journal-title":"Acta Ophthalmol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0275","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ophtha.2017.07.018","article-title":"Uveal melanoma nuclear BRCA1-Associated Protein-1 immunoreactivity is an Indicator of metastasis","volume":"125","author":"Szalai","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semcancer.2020.05.003_bib0280","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ajo.2018.03.005","article-title":"Correlation of immunocytochemistry of BRCA1-associated Protein-1 (BAP1) with other prognostic markers in Uveal Melanoma","volume":"189","author":"Glasgow","year":"2018","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0285","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ophtha.2010.05.023","article-title":"Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens","volume":"118","author":"Shields","year":"2011","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0290","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/ejhg.2015.35","article-title":"Guidelines for cytogenetic investigations in tumours","volume":"24","author":"Hastings","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0295","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ijc.10297","article-title":"Assessment of genomic instability in breast cancer and uveal melanoma by random amplified polymorphic DNA analysis","volume":"99","author":"Papadopoulos","year":"2002","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0300","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00008390-200310000-00001","article-title":"Instability of microsatellites is an infrequent event in uveal melanoma","volume":"13","author":"Cross","year":"2003","journal-title":"Melanoma Res."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0305","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0046-8177(95)90121-3","article-title":"DNA ploidy status in 84 ocular melanomas: a study of DNA quantitation in ocular melanomas by flow cytometry and automatic and interactive static image analysis","volume":"26","author":"Coleman","year":"1995","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0310","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-4608(90)90090-W","article-title":"Monosomy 3 and isochromosome 8q in a uveal melanoma","volume":"45","author":"Horsman","year":"1990","journal-title":"Cancer Genet. Cytogenet."},{"issue":"9010","key":"10.1016\/j.semcancer.2020.05.003_bib0315","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","article-title":"Prognostic implications of monosomy 3 in uveal melanoma","volume":"347","author":"Prescher","year":"1996","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.003_bib0320","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.ophtha.2007.06.012","article-title":"Cytogenetics of uveal melanoma: a 7-year clinical experience","volume":"114","author":"Damato","year":"2007","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0325","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/(SICI)1098-2264(199705)19:1<22::AID-GCC4>3.0.CO;2-2","article-title":"Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis","volume":"19","author":"Sisley","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0330","first-page":"1679","article-title":"Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization","volume":"42","author":"Parrella","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6009","key":"10.1016\/j.semcancer.2020.05.003_bib0335","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0340","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1158\/1078-0432.CCR-04-2054","article-title":"NBS1 expression as a prognostic marker in uveal melanoma","volume":"11","author":"Ehlers","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.003_bib0345","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1158\/1078-0432.CCR-04-1941","article-title":"DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma","volume":"11","author":"Ehlers","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.semcancer.2020.05.003_bib0350","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1158\/1078-0432.CCR-07-5144","article-title":"A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis","volume":"14","author":"Onken","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.003_bib0355","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1167\/iovs.04-1460","article-title":"Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients","volume":"46","author":"Kilic","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib0360","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ijc.21086","article-title":"Loss of heterozygosity of 1p in uveal melanomas with monosomy 3","volume":"116","author":"Hausler","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0365","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jamaophthalmol.2014.77","article-title":"Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival","volume":"132","author":"Damato","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.semcancer.2020.05.003_bib0370","article-title":"Uveal melanoma: towards a molecular understanding","author":"Smit","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0375","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med."},{"issue":"5573","key":"10.1016\/j.semcancer.2020.05.003_bib0380","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1126\/science.1071550","article-title":"G protein pathways","volume":"296","author":"Neves","year":"2002","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib0385","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/pcmr.12708","article-title":"Oncogenic signaling in uveal melanoma","volume":"31","author":"Park","year":"2018","journal-title":"Pigment Cell Melanoma Res."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib0390","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ng.3549","article-title":"Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma","volume":"48","author":"Moore","year":"2016","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib0395","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.18632\/oncotarget.6614","article-title":"Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4","volume":"7","author":"Johansson","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0400","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081061","article-title":"Molecular characteristics of uveal melanoma: insights from the cancer genome atlas (TCGA) project","volume":"11","author":"Bakhoum","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.003_bib0405","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","article-title":"BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression","volume":"16","author":"Jensen","year":"1998","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0410","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamaophthalmol.2015.1119","article-title":"Clinical characteristics of Uveal Melanoma in patients with germline BAP1 mutations","volume":"133","author":"Gupta","year":"2015","journal-title":"JAMA Ophthalmol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0415","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/gcc.22424","article-title":"Germline BAP1 alterations in familial uveal melanoma","volume":"56","author":"Rai","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0420","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/13816810.2015.1010734","article-title":"Analysis of BAP1 germline gene mutation in young uveal melanoma patients","volume":"36","author":"Cebulla","year":"2015","journal-title":"Ophthalmic Genet."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0425","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/1078-0432.CCR-11-0946","article-title":"Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma","volume":"18","author":"Landreville","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0430","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ophtha.2016.01.023","article-title":"Uveal melanomas with SF3B1 mutations: a distinct subclass associated with late-onset metastases","volume":"123","author":"Yavuzyigitoglu","year":"2016","journal-title":"Ophthalmology"},{"issue":"34","key":"10.1016\/j.semcancer.2020.05.003_bib0435","doi-asserted-by":"crossref","first-page":"E4726","DOI":"10.1073\/pnas.1514105112","article-title":"Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities","volume":"112","author":"Zhang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0440","first-page":"93","article-title":"The eighth edition AJCC Cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib0445","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamaophthalmol.2014.5395","article-title":"International validation of the american joint committee on cancer\u2019s 7th edition classification of uveal melanoma","volume":"133","year":"2015","journal-title":"JAMA Ophthalmol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0450","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1167\/iovs.16-20212","article-title":"The prognostic value of AJCC staging in uveal melanoma is enhanced by adding chromosome 3 and 8q status","volume":"58","author":"Dogrusoz","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.semcancer.2020.05.003_bib0455","article-title":"The decisionDx-UM gene expression profile test provides risk stratification and individualized patient care in Uveal Melanoma","volume":"5","author":"Harbour","year":"2013","journal-title":"PLoS Curr."},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.003_bib0460","first-page":"2578","article-title":"Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities","volume":"63","author":"Tschentscher","year":"2003","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0465","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","article-title":"Collaborative ocular oncology group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma","volume":"119","author":"Onken","year":"2012","journal-title":"Ophthalmology"},{"issue":"20","key":"10.1016\/j.semcancer.2020.05.003_bib0470","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-04-1750","article-title":"Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death","volume":"64","author":"Onken","year":"2004","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib0475","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CMR.0b013e3283005270","article-title":"Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis","volume":"18","author":"Chang","year":"2008","journal-title":"Melanoma Res."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0480","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2217\/14796694.4.5.629","article-title":"Emerging insights into the molecular pathogenesis of uveal melanoma","volume":"4","author":"Landreville","year":"2008","journal-title":"Future Oncol."},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.003_bib0485","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1167\/iovs.17-22255","article-title":"PRiMeUM: a model for predicting risk of metastasis in uveal melanoma","volume":"58","author":"Vaquero-Garcia","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0490","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.preteyeres.2011.05.003","article-title":"Estimating prognosis for survival after treatment of choroidal melanoma","volume":"30","author":"Damato","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0495","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020477","article-title":"Multicenter external validation of the liverpool uveal melanoma prognosticator online: an OOG collaborative study","volume":"12","author":"Cunha Rola","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0500","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/1078-0432.CCR-15-2071","article-title":"PRAME as an independent biomarker for metastasis in Uveal Melanoma","volume":"22","author":"Field","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"37","key":"10.1016\/j.semcancer.2020.05.003_bib0505","doi-asserted-by":"crossref","first-page":"59209","DOI":"10.18632\/oncotarget.10962","article-title":"Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in class 1 and class 2 uveal melanomas","volume":"7","author":"Field","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2020.05.003_bib0510","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ajo.2018.07.045","article-title":"Gene expression profiling and PRAME status versus tumor-node-metastasis staging for prognostication in Uveal Melanoma","volume":"195","author":"Cai","year":"2018","journal-title":"Am. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.003_bib0515","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00417-019-04335-w","article-title":"Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma","volume":"257","author":"Schefler","year":"2019","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0520","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.ophtha.2018.03.011","article-title":"The cancer genome atlas project: an integrated molecular view of uveal melanoma","volume":"125","author":"Jager","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semcancer.2020.05.003_bib0525","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2019.5710","article-title":"Accuracy of the cancer genome atlas classification vs american joint committee on cancer classification for prediction of metastasis in patients with uveal melanoma","author":"Mazloumi","year":"2020","journal-title":"JAMA Ophthalmol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0530","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.18632\/aging.102693","article-title":"Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis","volume":"12","author":"Pan","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.semcancer.2020.05.003_bib0535","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/OPTH.S199064","article-title":"Blood biomarkers of uveal melanoma: current perspectives","volume":"14","author":"Bande Rodriguez","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.semcancer.2020.05.003_bib0540","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/978-1-62703-727-3_21","article-title":"Clinical, pathologic, and imaging features and biological markers of uveal melanoma","volume":"1102","author":"Rashid","year":"2014","journal-title":"Methods Mol. Biol."},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.003_bib0545","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41571-019-0187-3","article-title":"Liquid biopsy and minimal residual disease - latest advances and implications for cure","volume":"16","author":"Pantel","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0550","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ccell.2017.01.002","article-title":"Liquid biopsies, what we do not know (yet)","volume":"31","author":"Bardelli","year":"2017","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0555","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000495113","article-title":"Uveal melanoma metastatic to the liver: treatment trends and outcomes","volume":"5","author":"Xu","year":"2019","journal-title":"Ocul. Oncol. Pathol."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0560","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1151::AID-CNCR20>3.0.CO;2-G","article-title":"Screening for metastatic malignant melanoma of the uvea revisited","volume":"85","author":"Eskelin","year":"1999","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0565","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.ophtha.2012.01.045","article-title":"Liver function testing is not helpful for early diagnosis of metastatic uveal melanoma","volume":"119","author":"Mouriaux","year":"2012","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.semcancer.2020.05.003_bib0570","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.2004.08.194","article-title":"Screening for metastasis from choroidal melanoma: the collaborative ocular melanoma study group report 23","volume":"22","author":"Diener-West","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2020.05.003_bib0575","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/OPTH.S199064","article-title":"Blood biomarkers of uveal melanoma: current perspectives","volume":"14","author":"Bande Rodr\u00edguez","year":"2020","journal-title":"Clin. Ophthalmol."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib0580","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1200\/JCO.2001.19.3.824","article-title":"Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma","volume":"19","author":"Martenson","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0585","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/archopht.121.8.1117","article-title":"Prognostic value of S-100-beta serum concentration in patients with uveal melanoma","volume":"121","author":"Missotten","year":"2003","journal-title":"Arch. Ophthalmol."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib0590","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00008390-200212000-00009","article-title":"Melanoma inhibitory activity: a novel serum marker for uveal melanoma","volume":"12","author":"Schaller","year":"2002","journal-title":"Melanoma Res."},{"issue":"11","key":"10.1016\/j.semcancer.2020.05.003_bib0595","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00417-005-1171-4","article-title":"\u201cMelanoma inhibitory activity\u201d (MIA): a promising serological tumour marker in metastatic uveal melanoma","volume":"243","author":"Reiniger","year":"2005","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"12","key":"10.1016\/j.semcancer.2020.05.003_bib0600","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1167\/iovs.15-17183","article-title":"ME20-S as a potential biomarker for the evaluation of uveal melanoma","volume":"56","author":"Bande","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib0605","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1167\/iovs.05-0422","article-title":"Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study","volume":"47","author":"Kadkol","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4a","key":"10.1016\/j.semcancer.2020.05.003_bib0610","first-page":"1897","article-title":"Serum markers to detect metastatic uveal melanoma","volume":"27","author":"Barak","year":"2007","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib0615","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3109\/02713683.2010.534573","article-title":"VEGF as a biomarker for metastatic uveal melanoma in humans","volume":"36","author":"Barak","year":"2011","journal-title":"Curr. Eye Res."},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.003_bib0620","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jamaophthalmol.2015.1766","article-title":"Potential role of soluble c-Met as a new candidate biomarker of metastatic uveal melanoma","volume":"133","author":"Barisione","year":"2015","journal-title":"JAMA Ophthalmol."},{"issue":"14","key":"10.1016\/j.semcancer.2020.05.003_bib0625","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1158\/1078-0432.CCR-08-0012","article-title":"Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma","volume":"14","author":"Ulmer","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0630","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1755-3768.2009.01617.x","article-title":"Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study","volume":"89","author":"Suesskind","year":"2011","journal-title":"Acta Ophthalmol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0635","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/cancers6010323","article-title":"Circulating tumor cells detection and counting in uveal melanomas by a filtration-based method","volume":"6","author":"Mazzini","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2020.05.003_bib0640","first-page":"323","article-title":"Circulating tumor cells detection and counting in uveal melanomas by a filtration-based method","author":"Cinzia","year":"2014","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0645","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/ijc.28436","article-title":"Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma","volume":"134","author":"Bidard","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2020.05.003_bib0650","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s13104-015-1420-5","article-title":"Detection of circulating melanoma cells in choroidal melanocytic lesions","volume":"8","author":"Bande","year":"2015","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.semcancer.2020.05.003_bib0655","article-title":"Pilot study of circulating tumor cells in early-stage and metastatic uveal melanoma","author":"Kartik","year":"2019","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0660","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/pcmr.12507","article-title":"Analysis of monosomy-3 in immunomagnetically isolated circulating melanoma cells in uveal melanoma patients","volume":"29","author":"Tura","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.semcancer.2020.05.003_bib0665","article-title":"Considerations and quality controls when analyzing cell-free tumor DNA","volume":"17","author":"Johansson","year":"2019","journal-title":"Biomol. Detect. Quantif."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0670","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1086\/302205","article-title":"Rapid clearance of fetal DNA from maternal plasma","volume":"64","author":"Lo","year":"1999","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.003_bib0675","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nm.1789","article-title":"Circulating mutant DNA to assess tumor dynamics","volume":"14","author":"Diehl","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2020.05.003_bib0680","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1038\/ncomms9760","article-title":"Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer","volume":"6","author":"Murtaza","year":"2015","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.003_bib0685","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/annonc\/mdu239","article-title":"Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle","volume":"25","author":"De Mattos-Arruda","year":"2014","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib0690","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2217\/fon.15.311","article-title":"The cobas(R) EGFR mutation test v2 assay","volume":"12","author":"Brown","year":"2016","journal-title":"Future Oncol."},{"key":"10.1016\/j.semcancer.2020.05.003_bib0695","article-title":"Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA","author":"Liu","year":"2020","journal-title":"Ann. Oncol."},{"issue":"14","key":"10.1016\/j.semcancer.2020.05.003_bib0700","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1158\/1078-0432.CCR-12-0309","article-title":"Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma","volume":"18","author":"Madic","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0705","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/cam4.61","article-title":"Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma","volume":"2","author":"Metz","year":"2013","journal-title":"Cancer Med."},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0710","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/annonc\/mdx212","article-title":"Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study","volume":"28","author":"Cabel","year":"2017","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0715","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/ijc.28436","article-title":"Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma","volume":"134","author":"Bidard","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0720","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/cam4.61","article-title":"Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma","volume":"2","author":"Metz","year":"2013","journal-title":"Cancer Med."},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0725","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/annonc\/mdx212","article-title":"Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study","volume":"28","author":"Cabel","year":"2017","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0730","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/s41467-018-04322-5","article-title":"Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors","volume":"9","author":"Rodrigues","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0735","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.molimm.2013.11.018","article-title":"Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease","volume":"58","author":"Achberger","year":"2014","journal-title":"Mol. Immunol."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib0740","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.8.6.12","article-title":"A panel of circulating MicroRNAs detects uveal melanoma with high precision","volume":"8","author":"Stark","year":"2019","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.003_bib0745","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1080\/15384047.2015.1046021","article-title":"miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: pathological and diagnostic implications","volume":"16","author":"Ragusa","year":"2015","journal-title":"Cancer Biol. Ther."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib0750","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","article-title":"Extracellular vesicles in cancer: cell-to-cell mediators of metastasis","volume":"30","author":"Becker","year":"2016","journal-title":"Cancer Cell"},{"issue":"7578","key":"10.1016\/j.semcancer.2020.05.003_bib0755","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib0760","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.003_bib0765","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41571-018-0036-9","article-title":"Extracellular vesicles in cancer - implications for future improvements in cancer care","volume":"15","author":"Xu","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2020.05.003_bib0770","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semcdb.2017.01.003","article-title":"Extracellular vesicle communication pathways as regulatory targets of oncogenic transformation","volume":"67","author":"Choi","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"issue":"12","key":"10.1016\/j.semcancer.2020.05.003_bib0775","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121979","article-title":"Engineered extracellular vesicles as a reliable tool in cancer nanomedicine","volume":"11","author":"Susa","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"3\u20134","key":"10.1016\/j.semcancer.2020.05.003_bib0780","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/prca.201400114","article-title":"Exosomes in bodily fluids are a highly stable resource of disease biomarkers","volume":"9","author":"Boukouris","year":"2015","journal-title":"Proteomics Clin. Appl."},{"issue":"31","key":"10.1016\/j.semcancer.2020.05.003_bib0785","doi-asserted-by":"crossref","first-page":"49623","DOI":"10.18632\/oncotarget.10418","article-title":"In-depth proteomic profiling of the uveal melanoma secretome","volume":"7","author":"Angi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2020.05.003_bib0790","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1186\/1471-2407-14-962","article-title":"MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma","volume":"14","author":"Eldh","year":"2014","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0795","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/s41598-019-38736-y","article-title":"Oncosuppressor-mutated cells as a liquid biopsy test for cancer-screening","volume":"9","author":"Abdouh","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0800","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1435138","article-title":"Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma","volume":"7","author":"Sharma","year":"2018","journal-title":"J. Extracell. Vesicles"},{"issue":"15","key":"10.1016\/j.semcancer.2020.05.003_bib0805","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153789","article-title":"An insight into the proteome of uveal melanoma-derived ectosomes reveals the presence of potentially useful biomarkers","volume":"20","author":"Surman","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0810","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-019-0964-8","article-title":"Emerging roles and therapeutic value of exosomes in cancer metastasis","volume":"18","author":"Wu","year":"2019","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.semcancer.2020.05.003_bib0815","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1158\/2159-8290.CD-12-0329","article-title":"The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination","volume":"2","author":"Labelle","year":"2012","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0820","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12307-008-0011-6","article-title":"The prometastatic microenvironment of the liver","volume":"1","author":"Vidal-Vanaclocha","year":"2008","journal-title":"Cancer Microenviron."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0825","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1167\/iovs.07-1035","article-title":"Differential expression of chemokine receptors on uveal melanoma cells and their metastases","volume":"49","author":"Li","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0830","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-017-0742-4","article-title":"Factors involved in cancer metastasis: a better understanding to \u201cseed and soil\u201d hypothesis","volume":"16","author":"Liu","year":"2017","journal-title":"Mol. Cancer"},{"issue":"24","key":"10.1016\/j.semcancer.2020.05.003_bib0835","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1158\/1078-0432.CCR-16-0460","article-title":"Role of the microenvironment in liver metastasis: from pre- to prometastatic niches","volume":"22","author":"Brodt","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib0840","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc.2017.6","article-title":"Pre-metastatic niches: organ-specific homes for metastases","volume":"17","author":"Peinado","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"35","key":"10.1016\/j.semcancer.2020.05.003_bib0845","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1038\/onc.2011.89","article-title":"Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis","volume":"30","author":"Burnier","year":"2011","journal-title":"Oncogene"},{"issue":"32","key":"10.1016\/j.semcancer.2020.05.003_bib0850","doi-asserted-by":"crossref","first-page":"52281","DOI":"10.18632\/oncotarget.12595","article-title":"The type I insulin-like growth factor regulates the liver stromal response to metastatic colon carcinoma cells","volume":"8","author":"Fernandez","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib0855","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1158\/0008-5472.CAN-05-2638","article-title":"The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0860","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1158\/0008-5472.CAN-09-2472","article-title":"Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis","volume":"70","author":"Wu","year":"2010","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.semcancer.2020.05.003_bib0865","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/jnci\/92.18.1472","article-title":"Role of the insulin-like growth factor family in cancer development and progression","volume":"92","author":"Yu","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.semcancer.2020.05.003_bib0870","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1755-3768.2008.01182.x","article-title":"Receptors for the liver synthesized growth factors IGF-1 and HGF\/SF in uveal melanoma: intercorrelation and prognostic implications","volume":"86","author":"Economou","year":"2008","journal-title":"Acta Ophthalmol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib0875","first-page":"1","article-title":"Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target","volume":"43","author":"All-Ericsson","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib0880","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/pcmr.12206","article-title":"Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth","volume":"27","author":"Yoshida","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"issue":"11","key":"10.1016\/j.semcancer.2020.05.003_bib0885","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1111\/jcmm.14623","article-title":"Pristimerin attenuates cell proliferation of uveal melanoma cells by inhibiting insulin-like growth factor-1 receptor and its downstream pathways","volume":"23","author":"Xie","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"12","key":"10.1016\/j.semcancer.2020.05.003_bib0890","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1158\/1078-0432.CCR-06-0818","article-title":"Targeting the c-Met signaling pathway in cancer","volume":"12","author":"Peruzzi","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib0895","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/02713680601161220","article-title":"Expression of epidermal growth factor receptor, ezrin, hepatocyte growth factor, and c-Met in uveal melanoma: an immunohistochemical study","volume":"32","author":"Mallikarjuna","year":"2007","journal-title":"Curr. Eye Res."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib0900","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/CMR.0000000000000118","article-title":"c-MET expression in primary and liver metastases in uveal melanoma","volume":"24","author":"Gardner","year":"2014","journal-title":"Melanoma Res."},{"issue":"13","key":"10.1016\/j.semcancer.2020.05.003_bib0905","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1158\/0008-5472.CAN-15-0370","article-title":"Paracrine effect of NRG1 and HGF drives resistance to MEK inhibitors in metastatic uveal melanoma","volume":"75","author":"Cheng","year":"2015","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.semcancer.2020.05.003_bib0910","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1158\/1535-7163.MCT-13-0499","article-title":"Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model","volume":"12","author":"Surriga","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.003_bib0915","first-page":"3144","article-title":"Stimulation and inhibition of uveal melanoma invasion by HGF, GRO, IL-1alpha and TGF-beta","volume":"43","author":"Woodward","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib0920","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00008390-200506000-00001","article-title":"Secretion of hepatocyte growth factor and vascular endothelial growth factor during uveal melanoma-monocyte in vitro interactions","volume":"15","author":"Cools-Lartigue","year":"2005","journal-title":"Melanoma Res."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib0925","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1158\/1078-0432.CCR-06-2630","article-title":"Molecular pathways mediating liver metastasis in patients with uveal melanoma","volume":"14","author":"Bakalian","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib0930","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1158\/1535-7163.MCT-16-0552","article-title":"Co-targeting HGF\/cMET signaling with MEK inhibitors in metastatic uveal melanoma","volume":"16","author":"Cheng","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.003_bib0935","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1158\/1078-0432.CCR-18-1368","article-title":"Arylsulfonamide 64B inhibits hypoxia\/HIF-induced expression of c-Met and CXCR4 and reduces primary tumor growth and metastasis of uveal melanoma","volume":"25","author":"Dong","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.semcancer.2020.05.003_bib0940","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1167\/iovs.09-3804","article-title":"Inhibition of chemokine receptor expression on uveal melanomas by CXCR4 siRNA and its effect on uveal melanoma liver metastases","volume":"50","author":"Li","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.semcancer.2020.05.003_bib0945","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2741\/e60","article-title":"CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression","volume":"2","author":"Franco","year":"2010","journal-title":"Front. Biosci. (Elite Ed.)"},{"issue":"12","key":"10.1016\/j.semcancer.2020.05.003_bib0950","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.1167\/iovs.13-12407","article-title":"Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance","volume":"54","author":"van den Bosch","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib0955","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1111\/j.1755-3768.2012.02515.x","article-title":"Expression of haematogenous and lymphogenous chemokine receptors and their ligands on uveal melanoma in association with liver metastasis","volume":"90","author":"Dobner","year":"2012","journal-title":"Acta Ophthalmol."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib0960","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav7504","article-title":"Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases","volume":"6","author":"Tan","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.semcancer.2020.05.003_bib0965","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.humpath.2016.07.012","article-title":"Metastatic ocular melanoma to the liver exhibits infiltrative and nodular growth patterns","volume":"57","author":"Grossniklaus","year":"2016","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib0970","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ophtha.2017.09.029","article-title":"Radiologic and histopathologic correlation of different growth patterns of metastatic uveal melanoma to the liver","volume":"125","author":"Liao","year":"2018","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.003_bib0975","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/bjc.2017.334","article-title":"International consensus guidelines for scoring the histopathological growth patterns of liver metastasis","volume":"117","author":"van Dam","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib0980","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/path.966","article-title":"Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia","volume":"195","author":"Vermeulen","year":"2001","journal-title":"J. Pathol."},{"issue":"11","key":"10.1016\/j.semcancer.2020.05.003_bib0985","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/nm.4197","article-title":"Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases","volume":"22","author":"Frentzas","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2020.05.003_bib0990","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6280347","article-title":"Liver metastases and histological growth patterns: biological behavior and potential clinical implications-another path to individualized medicine?","volume":"2019","author":"Oliveira","year":"2019","journal-title":"J. Oncol."},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.003_bib0995","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1158\/0008-5472.CAN-12-3931","article-title":"The multifaceted role of the microenvironment in liver metastasis: biology and clinical implications","volume":"73","author":"Van den Eynden","year":"2013","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib1000","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/cjp2.105","article-title":"Replacement and desmoplastic histopathological growth patterns: a pilot study of prediction of outcome in patients with uveal melanoma liver metastases","volume":"4","author":"Barnhill","year":"2018","journal-title":"J. Pathol. Clin. Res."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib1005","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1172\/JCI66369","article-title":"Hepatic stellate cells in liver development, regeneration, and cancer","volume":"123","author":"Yin","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib1010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/bjc.2016.155","article-title":"The impact of hepatic fibrosis on the incidence of liver metastasis from colorectal cancer","volume":"115","author":"Kondo","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib1015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081043","article-title":"Synergic interactions between hepatic stellate cells and uveal melanoma in metastatic growth","volume":"11","author":"Piquet","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib1020","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10585-013-9596-3","article-title":"Host pigment epithelium-derived factor (PEDF) prevents progression of liver metastasis in a mouse model of uveal melanoma","volume":"30","author":"Lattier","year":"2013","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib1025","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809081","article-title":"Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma","volume":"11","author":"Chua","year":"2019","journal-title":"EMBO Mol. Med."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib1030","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jamaophthalmol.2013.2547","article-title":"Progression of ocular melanoma metastasis to the liver: the 2012 Zimmerman lecture","volume":"131","author":"Grossniklaus","year":"2013","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.semcancer.2020.05.003_bib1035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.exer.2019.02.012","article-title":"The bidirectional crosstalk between metastatic uveal melanoma cells and hepatic stellate cells engenders an inflammatory microenvironment","volume":"181","author":"Babchia","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.semcancer.2020.05.003_bib1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119478","article-title":"Precision detection of liver metastasis by collagen-targeted protein MRI contrast agent","volume":"224","author":"Salarian","year":"2019","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib1045","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/labinvest.2013.139","article-title":"Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model","volume":"94","author":"Zhao","year":"2014","journal-title":"Lab. Invest."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib1050","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1309\/AJCP86PPBNGOHNNL","article-title":"Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection","volume":"131","author":"Ju","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib1055","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.4049\/jimmunol.1500139","article-title":"Hepatic stellate cells inhibit t cells through active TGF-beta1 from a cell surface-bound latent TGF-beta1\/GARP complex","volume":"195","author":"Li","year":"2015","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib1060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1189\/jlb.2A0516-239R","article-title":"Hepatic stellate cells increase the immunosuppressive function of natural Foxp3+ regulatory T cells via IDO-induced AhR activation","volume":"101","author":"Kumar","year":"2017","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib1065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030879","article-title":"The role of immune checkpoint blockade in Uveal Melanoma","volume":"21","author":"Wessely","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib1070","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1470-2045(17)30251-6","article-title":"Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study","volume":"18","author":"Chandran","year":"2017","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib1075","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1321187","article-title":"Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: a pilot study","volume":"6","author":"Qin","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcancer.2020.05.003_bib1080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.humpath.2017.06.005","article-title":"Inflammatory cell infiltrates in advanced metastatic uveal melanoma","volume":"66","author":"Krishna","year":"2017","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib1085","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/path.5384","article-title":"Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development","volume":"250","author":"Figueiredo","year":"2020","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib1090","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41467-019-14256-1","article-title":"Single-cell analysis reveals new evolutionary complexity in uveal melanoma","volume":"11","author":"Durante","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2020.05.003_bib1095","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4521807","article-title":"Animal models of uveal melanoma: methods, applicability, and limitations","volume":"2016","author":"Stei","year":"2016","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.semcancer.2020.05.003_bib1100","series-title":"Clinical Ophthalmic Oncology: Uveal Tumors","first-page":"135","article-title":"Animal models in uveal melanoma","author":"Burnier","year":"2019"},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib1105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000370153","article-title":"Uveal melanoma metastasis models","volume":"1","author":"Yang","year":"2015","journal-title":"Ocul. Oncol. Pathol."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib1110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1023\/A:1018479011340","article-title":"Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease","volume":"15","author":"Chen","year":"1997","journal-title":"Clin. Exp. Metastasis"},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib1115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00008390-200508000-00005","article-title":"Characterization of the typical multidrug resistance profile in human uveal melanoma cell lines and in mouse liver metastasis derivatives","volume":"15","author":"Labialle","year":"2005","journal-title":"Melanoma Res."},{"key":"10.1016\/j.semcancer.2020.05.003_bib1120","first-page":"1101","article-title":"MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment","volume":"11","author":"Berube","year":"2005","journal-title":"Mol. Vis."},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib1125","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.molonc.2014.06.004","article-title":"Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target","volume":"8","author":"Amirouchene-Angelozzi","year":"2014","journal-title":"Mol. Oncol."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib1130","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1158\/1541-7786.MCR-18-0574","article-title":"Effects of oncogenic galphaq and Galpha11 inhibition by FR900359 in Uveal Melanoma","volume":"17","author":"Lapadula","year":"2019","journal-title":"Mol. Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib1135","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020405","article-title":"Expression of tryptophan 2,3-Dioxygenase in metastatic uveal melanoma","volume":"12","author":"Terai","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib1140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080836","article-title":"Targeting Bcl-2\/Bcl-XL induces antitumor activity in uveal melanoma patient-derived xenografts","volume":"9","author":"Nemati","year":"2014","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.semcancer.2020.05.003_bib1145","doi-asserted-by":"crossref","first-page":"23633","DOI":"10.18632\/oncotarget.8054","article-title":"The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma","volume":"7","author":"Amirouchene-Angelozzi","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib1150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000370154","article-title":"Uveal melanoma patient-derived xenografts","volume":"1","author":"Carita","year":"2015","journal-title":"Ocul. Oncol. Pathol."},{"issue":"31","key":"10.1016\/j.semcancer.2020.05.003_bib1155","doi-asserted-by":"crossref","first-page":"21674","DOI":"10.18632\/oncotarget.24670","article-title":"Selumetinib-based therapy in uveal melanoma patient-derived xenografts","volume":"9","author":"Decaudin","year":"2018","journal-title":"Oncotarget"},{"issue":"23","key":"10.1016\/j.semcancer.2020.05.003_bib1160","doi-asserted-by":"crossref","first-page":"33542","DOI":"10.18632\/oncotarget.9552","article-title":"Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma","volume":"7","author":"Carita","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib1165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/pcmr.12577","article-title":"Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient-derived xenografts","volume":"30","author":"Crepin","year":"2017","journal-title":"Pigment Cell Melanoma Res."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib1170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060751","article-title":"PARP inhibition increases the response to chemotherapy in Uveal Melanoma","volume":"11","author":"de Koning","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib1175","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1167\/iovs.15-18780","article-title":"Protein tyrosine phosphatase 4A3 (PTP4A3) promotes human uveal melanoma aggressiveness through membrane accumulation of matrix metalloproteinase 14 (MMP14)","volume":"57","author":"Maacha","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.semcancer.2020.05.003_bib1180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejca.2019.12.012","article-title":"Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2\/XL\/W and MDM2 as a potential therapy in uveal melanoma","volume":"126","author":"Decaudin","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.semcancer.2020.05.003_bib1185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.addr.2017.05.018","article-title":"Engineering in vitro models of hepatofibrogenesis","volume":"121","author":"Mazza","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.semcancer.2020.05.003_bib1190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pharmthera.2017.10.018","article-title":"Emerging tumor spheroids technologies for 3D in vitro cancer modeling","volume":"184","author":"Rodrigues","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.semcancer.2020.05.003_bib1195","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ddtec.2017.03.002","article-title":"The production of 3D tumor spheroids for cancer drug discovery","volume":"23","author":"Sant","year":"2017","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.semcancer.2020.05.003_bib1200","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.actbio.2018.08.008","article-title":"Multicellular spheroid based on a triple co-culture: a novel 3D model to mimic pancreatic tumor complexity","volume":"78","author":"Lazzari","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.semcancer.2020.05.003_bib1205","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6051210","article-title":"Human organ-specific 3D Cancer models produced by the stromal self-assembly method of tissue engineering for the study of solid tumors","volume":"2020","author":"Roy","year":"2020","journal-title":"Biomed Res. Int."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib1210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10585-018-9894-x","article-title":"Expression of the serotonin receptor 2B in uveal melanoma and effects of an antagonist on cell lines","volume":"35","author":"Weidmann","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"issue":"19","key":"10.1016\/j.semcancer.2020.05.003_bib1215","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00700-18","article-title":"Herpes simplex virus 1 infection promotes the growth of a subpopulation of tumor cells in three-dimensional uveal melanoma cultures","volume":"92","author":"Valyi-Nagy","year":"2018","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.003_bib1220","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091344","article-title":"The potential use of electrochemotherapy in the treatment of Uveal Melanoma: in vitro results in 3D tumor cultures and in vivo results in a chick embryo model","volume":"11","author":"Fiorentzis","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2020.05.003_bib1225","first-page":"680","article-title":"Multicellular tumor spheroids of human uveal melanoma induce genes associated with anoikis resistance, lipogenesis, and SSXs","volume":"23","author":"Ness","year":"2017","journal-title":"Mol. Vis."},{"issue":"11","key":"10.1016\/j.semcancer.2020.05.003_bib1230","doi-asserted-by":"crossref","first-page":"8458","DOI":"10.1167\/iovs.11-7379","article-title":"Uveal melanoma cell lines contain stem-like cells that self-renew, produce differentiated progeny, and survive chemotherapy","volume":"52","author":"Kalirai","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib1235","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/cgt.2009.73","article-title":"Identification of virus resistant tumor cell subpopulations in three-dimensional uveal melanoma cultures","volume":"17","author":"Valyi-Nagy","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.semcancer.2020.05.003_bib1240","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.actbio.2018.11.033","article-title":"Characterization of a tissue-engineered choroid","volume":"84","author":"Djigo","year":"2019","journal-title":"Acta Biomater."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib1245","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s11626-999-0081-x","article-title":"Characterization of a new tissue-engineered human skin equivalent with hair","volume":"35","author":"Michel","year":"1999","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib1250","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","article-title":"Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids","volume":"30","author":"Ouchi","year":"2019","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib1255","article-title":"Organ-on-a-chip for cancer and immune organs modeling","volume":"8","author":"Sun","year":"2019","journal-title":"Adv. Healthc. Mater."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib1260","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/ceo.12814","article-title":"Novel mouse model for primary uveal melanoma: a pilot study","volume":"45","author":"Susskind","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib1265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajpath.2015.09.011","article-title":"Establishment and characterization of orthotopic mouse models for human uveal melanoma hepatic colonization","volume":"186","author":"Ozaki","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"15","key":"10.1016\/j.semcancer.2020.05.003_bib1270","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1158\/1078-0432.CCR-17-1703","article-title":"Neddylation blockade diminishes hepatic metastasis by dampening cancer stem-like cells and angiogenesis in Uveal Melanoma","volume":"24","author":"Jin","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.003_bib1275","first-page":"1080","article-title":"Enucleation in consort with immunologic impairment promotes metastasis of intraocular melanomas in mice","volume":"25","author":"Niederkorn","year":"1984","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib1280","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00008390-200002000-00001","article-title":"A new technique for implantation of tissue culture melanoma cells in a murine model of metastatic ocular melanoma","volume":"10","author":"Dithmar","year":"2000","journal-title":"Melanoma Res."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib1285","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ccell.2016.04.015","article-title":"ARF6 is an actionable node that orchestrates oncogenic GNAQ signaling in Uveal Melanoma","volume":"29","author":"Yoo","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib1290","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/02713683.2015.1004721","article-title":"Intravitreally injected HCmel12 melanoma cells serve as a mouse model of tumor biology of intraocular melanoma","volume":"41","author":"Kilian","year":"2016","journal-title":"Curr. Eye Res."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib1295","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/pcmr.12853","article-title":"Mouse models of uveal melanoma: strengths, weaknesses, and future directions","volume":"33","author":"Richards","year":"2020","journal-title":"Pigment Cell Melanoma Res."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib1300","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12967-017-1247-z","article-title":"Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis","volume":"15","author":"Kageyama","year":"2017","journal-title":"J. Transl. Med."},{"issue":"13","key":"10.1016\/j.semcancer.2020.05.003_bib1305","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1167\/iovs.16-19317","article-title":"Effects of long-term serial passaging on the characteristics and properties of cell lines derived from uveal melanoma primary tumors","volume":"57","author":"Mouriaux","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib1310","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1755-148X.2011.00841.x","article-title":"ABCB1 identifies a subpopulation of uveal melanoma cells with high metastatic propensity","volume":"24","author":"Landreville","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib1315","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1755-148X.2011.00869.x","article-title":"Suppression of alpha5 gene expression is closely related to the tumorigenic properties of uveal melanoma cell lines","volume":"24","author":"Landreville","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib1320","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/pcmr.12306","article-title":"ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion","volume":"27","author":"Gangemi","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib1325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029989","article-title":"Mda-9\/syntenin is expressed in uveal melanoma and correlates with metastatic progression","volume":"7","author":"Gangemi","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib1330","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nm.3853","article-title":"Translational value of mouse models in oncology drug development","volume":"21","author":"Gould","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2020.05.003_bib1335","first-page":"T5","article-title":"Uveal melanoma cell lines: where do they come from? (an American Ophthalmological Society Thesis)","volume":"114","author":"Jager","year":"2016","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.semcancer.2020.05.003_bib1340","first-page":"153","article-title":"Generation of a liver orthotopic human uveal melanoma xenograft platform in immunodeficient mice","author":"Kageyama","year":"2019","journal-title":"J. Vis. Exp."},{"issue":"11","key":"10.1016\/j.semcancer.2020.05.003_bib1345","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ng.3967","article-title":"Patient-derived xenografts undergo mouse-specific tumor evolution","volume":"49","author":"Ben-David","year":"2017","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib1350","doi-asserted-by":"crossref","first-page":"137","DOI":"10.15252\/emmm.201606857","article-title":"Genetically engineered mouse models in oncology research and cancer medicine","volume":"9","author":"Kersten","year":"2017","journal-title":"EMBO Mol. Med."},{"issue":"16","key":"10.1016\/j.semcancer.2020.05.003_bib1355","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1158\/0008-5472.CAN-14-3229","article-title":"Oncogenic g protein GNAQ induces uveal melanoma and intravasation in mice","volume":"75","author":"Huang","year":"2015","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.003_bib1360","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.celrep.2018.01.081","article-title":"GNA11 Q209L mouse model reveals RasGRP3 as an essential signaling node in Uveal Melanoma","volume":"22","author":"Moore","year":"2018","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.003_bib1365","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1016\/j.celrep.2019.03.021","article-title":"YAP\/TAZ activation drives uveal melanoma initiation and progression","volume":"29","author":"Li","year":"2019","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib1370","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.2967\/jnumed.118.217240","article-title":"Melanocortin 1 receptor-targeted alpha-particle therapy for metastatic uveal melanoma","volume":"60","author":"Tafreshi","year":"2019","journal-title":"J. Nucl. Med."},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.003_bib1375","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41590-019-0416-z","article-title":"Humanized immune system mouse models: progress, challenges and opportunities","volume":"20","author":"Allen","year":"2019","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib1380","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s40259-018-0275-4","article-title":"Humanized mouse models for the preclinical assessment of cancer immunotherapy","volume":"32","author":"Wege","year":"2018","journal-title":"BioDrugs"},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib1385","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.4049\/jimmunol.1203543","article-title":"Establishment of a human allergy model using human IL-3\/GM-CSF-transgenic NOG mice","volume":"191","author":"Ito","year":"2013","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib1390","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1096\/fj.201700740R","article-title":"Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy","volume":"32","author":"Wang","year":"2018","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.semcancer.2020.05.003_bib1395","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1167\/iovs.04-1103","article-title":"Characterization of ocular and metastatic uveal melanoma in an animal model","volume":"46","author":"Blanco","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib1400","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1167\/iovs.17-22197","article-title":"Quantitative evaluation of vascular microcirculation using contrast-enhanced ultrasound imaging in rabbit models of choroidal melanoma","volume":"59","author":"Gao","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib1405","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1158\/1535-7163.MCT-17-0953","article-title":"An infrared dye-conjugated virus-like particle for the treatment of primary uveal melanoma","volume":"17","author":"Kines","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib1410","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0008-4182(04)80017-6","article-title":"Experimental models of uveal melanoma","volume":"39","author":"Blanco","year":"2004","journal-title":"Can. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib1415","doi-asserted-by":"crossref","first-page":"10448","DOI":"10.1038\/s41598-018-28515-6","article-title":"Angiotropism and extravascular migratory metastasis in cutaneous and uveal melanoma progression in a zebrafish model","volume":"8","author":"Fornabaio","year":"2018","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.003_bib1420","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1167\/iovs.14-15202","article-title":"Modeling of human uveal melanoma in zebrafish xenograft embryos","volume":"55","author":"van der Ent","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"26","key":"10.1016\/j.semcancer.2020.05.003_bib1425","doi-asserted-by":"crossref","first-page":"39654","DOI":"10.18632\/oncotarget.9207","article-title":"Minimal contribution of ERK1\/2-MAPK signalling towards the maintenance of oncogenic GNAQQ209P-driven uveal melanomas in zebrafish","volume":"7","author":"Mouti","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib1430","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/pcmr.12700","article-title":"Uveal melanoma driver mutations in GNAQ\/11 yield numerous changes in melanocyte biology","volume":"31","author":"Perez","year":"2018","journal-title":"Pigment Cell Melanoma Res."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib1435","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000370151","article-title":"Use of the chick embryo model in Uveal Melanoma","volume":"1","author":"Kalirai","year":"2015","journal-title":"Ocul. Oncol. Pathol."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib1440","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/0008-5472.CAN-10-0605","article-title":"High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients","volume":"71","author":"Laurent","year":"2011","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib1445","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/bbrc.1993.1376","article-title":"A chicken embryo model to study the growth of human uveal melanoma","volume":"192","author":"Luyten","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.003_bib1450","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jamaophthalmol.2018.2466","article-title":"Survival rates in patients after treatment for metastasis from uveal melanoma","volume":"136","author":"Lane","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.semcancer.2020.05.003_bib1455","doi-asserted-by":"crossref","DOI":"10.1177\/1758834018757175","article-title":"Treatment of uveal melanoma: where are we now?","volume":"10","author":"Yang","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib1460","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050694","article-title":"New insights into molecular oncogenesis and therapy of uveal melanoma","volume":"11","author":"Violanti","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.003_bib1465","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.ejso.2019.06.036","article-title":"Iterative treatment with surgery and radiofrequency ablation of uveal melanoma liver metastasis: retrospective analysis of a series of very long-term survivors","volume":"45","author":"Servois","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib1470","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ejso.2016.02.019","article-title":"Radiofrequency ablation and surgical resection of liver metastases from uveal melanoma","volume":"42","author":"Mariani","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib1475","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40257-017-0325-6","article-title":"Advanced melanoma: current treatment options, biomarkers, and future perspectives","volume":"19","author":"Rozeman","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.semcancer.2020.05.003_bib1480","article-title":"Systematic review of liver directed therapy for uveal melanoma hepatic metastases","author":"Rowcroft","year":"2019","journal-title":"HPB (Oxford)"},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib1485","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1158\/1078-0432.CCR-10-3169","article-title":"Therapeutic implications of the emerging molecular biology of uveal melanoma","volume":"17","author":"Patel","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.semcancer.2020.05.003_bib1490","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.2014.6096","article-title":"Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial","volume":"311","author":"Carvajal","year":"2014","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib1495","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/1097-0142(19830715)52:2<334::AID-CNCR2820520225>3.0.CO;2-E","article-title":"Survival in metastatic ocular melanoma","volume":"52","author":"Rajpal","year":"1983","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib1500","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0161-6420(91)32285-1","article-title":"Survival of patients with metastases from uveal melanoma","volume":"98","author":"Gragoudas","year":"1991","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.003_bib1505","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/1097-0142(19931001)72:7<2219::AID-CNCR2820720725>3.0.CO;2-J","article-title":"Prognosis and treatment of disseminated uveal melanoma","volume":"72","author":"Kath","year":"1993","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.semcancer.2020.05.003_bib1510","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/1097-0142(19951101)76:9<1665::AID-CNCR2820760925>3.0.CO;2-J","article-title":"Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors","volume":"76","author":"Bedikian","year":"1995","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib1515","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archopht.1996.01100130103030","article-title":"Metastatic ocular and cutaneous melanoma: a comparison of patient characteristics and prognosis","volume":"114","author":"Albert","year":"1996","journal-title":"Arch. Ophthalmol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib1520","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cncr.11113","article-title":"A prognostic model and staging for metastatic uveal melanoma","volume":"97","author":"Eskelin","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2020.05.003_bib1525","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/cncr.11872","article-title":"Prolonged survival after complete resection of metastases from intraocular melanoma","volume":"100","author":"Hsueh","year":"2004","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.semcancer.2020.05.003_bib1530","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.2004.08.194","article-title":"Screening for metastasis from choroidal melanoma: the collaborative ocular melanoma study group report 23","volume":"22","author":"Diener-West","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"31","key":"10.1016\/j.semcancer.2020.05.003_bib1535","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.1200\/JCO.2005.02.6534","article-title":"Variates of survival in metastatic uveal melanoma","volume":"23","author":"Rietschel","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.semcancer.2020.05.003_bib1540","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00417-005-1188-8","article-title":"Prognostic factors of liver metastases from uveal melanoma","volume":"243","author":"Kodjikian","year":"2005","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib1545","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1245\/ASO.2005.06.032","article-title":"Treatment of liver metastases from uveal melanoma","volume":"12","author":"Rivoire","year":"2005","journal-title":"Ann. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.semcancer.2020.05.003_bib1550","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/bjo.2008.153684","article-title":"Long-term survival of uveal melanoma patients after surgery for liver metastases","volume":"93","author":"Frenkel","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.003_bib1555","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archophthalmol.2010.121","article-title":"Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma","volume":"128","author":"Kim","year":"2010","journal-title":"Arch. Ophthalmol."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib1560","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/bjophthalmol-2012-302323","article-title":"MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients","volume":"97","author":"Marshall","year":"2013","journal-title":"Br. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib1565","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/COC.0b013e3182546a6b","article-title":"Delayed systemic recurrence of uveal melanoma","volume":"36","author":"Kolandjian","year":"2013","journal-title":"Am. J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.003_bib1570","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1111\/aos.12168","article-title":"Mortality from uveal melanoma treated by enucleation --a 16-year survey in Taiwan","volume":"91","author":"Liu","year":"2013","journal-title":"Acta Ophthalmol."},{"issue":"3","key":"10.1016\/j.semcancer.2020.05.003_bib1575","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000358729","article-title":"Clinical presentation, pathological features and natural course of metastatic uveal melanoma, an orphan and commonly fatal disease","volume":"86","author":"Cerbone","year":"2014","journal-title":"Oncology"},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib1580","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jfo.2015.04.005","article-title":"Prospective study of surveillance testing for metastasis in 100 high-risk uveal melanoma patients","volume":"38","author":"Piperno-Neumann","year":"2015","journal-title":"J. Fr. Ophtalmol."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib1585","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/ceo.12490","article-title":"Survival from uveal melanoma in Western Australia 1981-2005","volume":"43","author":"Chew","year":"2015","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.003_bib1590","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1634\/theoncologist.2015-0522","article-title":"Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasis","volume":"21","author":"Kuk","year":"2016","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib1595","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.4143\/crt.2017.534","article-title":"Prognoses and clinical outcomes of primary and recurrent uveal melanoma","volume":"50","author":"Kim","year":"2018","journal-title":"Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.semcancer.2020.05.003_bib1600","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/CMR.0000000000000468","article-title":"Prognostic factors for first-line therapy and overall survival of metastatic uveal melanoma: the princess margaret cancer centre experience","volume":"28","author":"Nicholas","year":"2018","journal-title":"Melanoma Res."},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib1605","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10384-019-00656-9","article-title":"Clinical predictors of survival in metastatic uveal melanoma","volume":"63","author":"Lorenzo","year":"2019","journal-title":"Jpn. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.semcancer.2020.05.003_bib1610","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11071007","article-title":"Metastatic uveal melanoma: treatment strategies and survival-results from the dutch melanoma treatment registry","volume":"11","author":"Jochems","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.semcancer.2020.05.003_bib1615","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12032-018-1230-4","article-title":"Risk factors, clinical outcomes, and natural history of uveal melanoma: a single-institution analysis","volume":"36","author":"Delgado-Ramos","year":"2019","journal-title":"Med. Oncol."},{"issue":"4","key":"10.1016\/j.semcancer.2020.05.003_bib1620","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041048","article-title":"Transplantable melanomas in hamsters and gerbils as models for human melanoma. sensitization in melanoma radiotherapy-from animal models to clinical trials","volume":"19","author":"\u015aniegocka","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.semcancer.2020.05.003_bib1625","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1158\/1535-7163.MCT-13-0550","article-title":"The phosphoinositide 3-kinase \u03b1 selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ\/GNA11-mutant uveal melanoma cells","volume":"13","author":"Musi","year":"2014","journal-title":"Mol. Cancer Ther."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X20300997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X20300997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:42:28Z","timestamp":1778582548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X20300997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":325,"alternative-id":["S1044579X20300997"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2020.05.003","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uveal melanoma pathobiology: Metastasis to the liver","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2020.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}